Мақаланы E-mail арқылы жіберу Conjugates of Prostate-Specific Membrane Antigen Ligands with Antitumor Drugs
- Авторлар: Uspenskaya A.A.1, Machulkin A.É.1, Mazhuga A.G.1,2, Beloglazkina E.K.1
-
Мекемелер:
- Department of Chemistry, M. V. Lomonosov Moscow State University
- D. Mendeleev University of Chemical Technology of Russia
- Шығарылым: Том 53, № 4 (2019)
- Беттер: 288-297
- Бөлім: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/245738
- DOI: https://doi.org/10.1007/s11094-019-01994-1
- ID: 245738
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Тек жазылушылар үшін
Аннотация
Conjugates for targeted delivery that are based on low-molecular-mass prostate specific membrane antigen (PSMA) inhibitors are widely used and developed because of the deficiencies of existing methods for treating and diagnosing prostate cancer. The major classes of low-molecular-mass PSMA inhibitors, drug classes, and their mechanisms of action are discussed. Therapeutic conjugates for targeted delivery that are based on them are analyzed. Structural features of the linker that affect the biological activity and selectivity are identified.
Негізгі сөздер
Авторлар туралы
A. Uspenskaya
Department of Chemistry, M. V. Lomonosov Moscow State University
Хат алмасуға жауапты Автор.
Email: uspenskaya.n@gmail.com
Ресей, GSP-1, Moscow, 199991
A. Machulkin
Department of Chemistry, M. V. Lomonosov Moscow State University
Email: uspenskaya.n@gmail.com
Ресей, GSP-1, Moscow, 199991
A. Mazhuga
Department of Chemistry, M. V. Lomonosov Moscow State University; D. Mendeleev University of Chemical Technology of Russia
Email: uspenskaya.n@gmail.com
Ресей, GSP-1, Moscow, 199991; Moscow, 125047
E. Beloglazkina
Department of Chemistry, M. V. Lomonosov Moscow State University
Email: uspenskaya.n@gmail.com
Ресей, GSP-1, Moscow, 199991
Қосымша файлдар
